Skip to Content

Alphatec Holdings Inc ATEC

Morningstar Rating
$12.54 +0.20 (1.62%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATEC is trading at a 37% discount.
Price
$12.48
Fair Value
$17.51
Uncertainty
Very High
1-Star Price
$26.40
5-Star Price
$4.41
Economic Moat
Zyld
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATEC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$12.34
Day Range
$12.2712.79
52-Week Range
$8.6619.14
Bid/Ask
$12.21 / $12.88
Market Cap
$1.73 Bil
Volume/Avg
1.3 Mil / 1.7 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.15
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
839

Comparables

Valuation

Metric
ATEC
LUNG
OBIO
Price/Earnings (Normalized)
Price/Book Value
22.342.442.48
Price/Sales
3.154.1556.70
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ATEC
LUNG
OBIO
Quick Ratio
1.865.627.82
Current Ratio
2.866.507.95
Interest Coverage
−10.23−19.37
Quick Ratio
ATEC
LUNG
OBIO

Profitability

Metric
ATEC
LUNG
OBIO
Return on Assets (Normalized)
−9.89%−22.61%−35.16%
Return on Equity (Normalized)
−31.80%−51.40%
Return on Invested Capital (Normalized)
−9.94%−25.75%−50.12%
Return on Assets
ATEC
LUNG
OBIO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHgmpgdhyLncgfgg$182.7 Bil
SYK
Stryker CorpZhtjrmdqmFrh$124.6 Bil
MDT
Medtronic PLCCtkwhcgkDlhjd$105.2 Bil
BSX
Boston Scientific CorpWyfyyvvdDxvhkk$99.0 Bil
DXCM
DexCom IncZfttvqvzcLdc$51.8 Bil
EW
Edwards Lifesciences CorpDkrkmwhmfMdwkr$51.7 Bil
ZBH
Zimmer Biomet Holdings IncXzzhvmjqlJzby$24.5 Bil
ALGN
Align Technology IncXjnfzqxpHsnrssy$22.5 Bil
PHG
Koninklijke Philips NV ADRLjqxmdxRdwqpc$18.3 Bil
PODD
Insulet CorpCggffmngmHfwxcd$11.6 Bil

Sponsor Center